Skip to content
News Center
About Us Careers News Center Contact Us Legal Video Hub iHope Doing Business with Illumina Investors Illumina for Startups Home

Corporate

Video: Inside the UK’s largest life sciences event

Illumina leaders and other industry experts convene in London for the ninth annual Festival of Genomics & Biodata

Inside the UK’s largest life sciences event
January 29, 2024
For a printable PDF of this article, click here.
To listen to this article read aloud, click here.
 
On January 24 and 25, 2024, the Festival of Genomics & Biodata (FoG) at ExCeL London showcased the latest advancements in genomics and life sciences. FoG’s core mission is to accelerate the delivery of genomics to benefit patients. The largest annual life sciences event in the United Kingdom, the festival brought together more than 5000 attendees in a vibrant and collaborative setting for exploring, networking, and exchanging groundbreaking ideas. This year’s festival featured a dynamic program including over 280 speakers, 12 theaters, “the Genome Dome,” roundtable discussions, workshops, and more.
 

As lead sponsor of the event, Illumina conducted two keynote sessions. Patrick Tarpey, PhD, lead clinical scientist for Solid Cancer at the East Genomic Laboratory Hub at Cambridge University Hospitals NHS, led a panel discussion on the first day, exploring the “Expansive Analysis of NGS Data in Solid Cancer” and unveiling innovative approaches in genomic data analysis. The next day featured Ana-Maria Cujba, PhD, from the Wellcome Sanger Institute, who presented “Harnessing Single-Cell and Spatial Technologies for Human Cell Atlasing in Health and Disease.”

At the Illumina booth, the spotlight was on the new P4 flow cell powered by XLEAP-SBS chemistry for the NextSeq 2000 System. The Illumina team also demonstrated the tertiary analysis capabilities of the company’s Emedgene software, which can offer insights into hereditary disease variant interpretation.
 

The highlight of the Illumina booth this year was the captivating Lego NovaSeq X.
Previous Article
Next Article

Recent Articles

Inspiring young minds: HRH The Princess Royal helps Illumina celebrate DNA Day
Inspiring young minds: HRH The Princess Royal helps Illumina celebrate DNA Day
Engineering a cool career in biotech—and volunteering along the way
Engineering a cool career in biotech—and volunteering along the way
Evidence supports sequencing as first-line rare disease diagnostic
Evidence supports sequencing as first-line rare disease diagnostic
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.